EVGN
EvogeneNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.29M
P/E Ratio
—
EPS
$-1.70
Beta
0.80
52W High
$2.42
52W Low
$0.66
50-Day MA
$0.79
200-Day MA
$1.04
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Evogene
Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | $1.84M |
| Gross Profit (TTM) | -863,000 |
| EBITDA | $-13.49M |
| Operating Margin | -943.00% |
| Return on Equity | -171.80% |
| Return on Assets | -33.30% |
| Revenue/Share (TTM) | $0.21 |
| Book Value | $-0.01 |
| Price-to-Book | 6.18 |
| Price-to-Sales (TTM) | 3.95 |
| EV/Revenue | 1.165 |
| EV/EBITDA | -0.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -86.30% |
| Shares Outstanding | $10.41M |
| Float | $10.33M |
| % Insiders | 0.96% |
| % Institutions | 6.25% |
Historical Volatility
HV 10-Day
53.17%
HV 20-Day
45.58%
HV 30-Day
45.36%
HV 60-Day
60.50%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($2.25 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026